Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tetrabenazine (Standard)

Tetrabenazine (Standard) is the analytical standard of Tetrabenazine. This product is intended for research and analytical applications. Tetrabenazine (Ro 1-9569) is a reversible inhibitor of the vesicular monoamine transporter VMAT2 with the Kd value of 1.34 nM. Tetrabenazine can be used for research on diseases related to hyperactive movement disorders such as Huntington's disease[1][2][3].

Product Specifications

CAS Number

[58-46-8]

Product Name Alternative

Ro 1-9569 (Standard)

UNSPSC

12352005

Target

Monoamine Transporter; Reference Standards

Related Pathways

Membrane Transporter/Ion Channel; Others

Field of Research

Neurological Disease

Smiles

O=C1[C@@H](CC(C)C)CN2CCC3=CC(OC)=C(OC)C=C3[C@]2([H])C1

Molecular Formula

C19H27NO3

Molecular Weight

317.43

References & Citations

[1]Jankovic, J. and J. Beach, Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology, 1997. 48 (2) : p. 358-62.|[2]Kenney, C., C. Hunter, and J. Jankovic, Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord, 2007. 22 (2) : p. 193-7.|[3]Ondo, W.G., P.A. Hanna, and J. Jankovic, Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Am J Psychiatry, 1999. 156 (8) : p. 1279-81.|[4]J C Shih, et al. Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A. Brain Res. 1999 Jul 24;835 (2) :104-12.|[5] Nobue Kitanaka, et al. Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex. Pharmacol Biochem Behav. 2018 Sep;172:9-16. doi: 10.1016/j.pbb.2018.07.002. Epub 2018 Jul 12.|[6]S J Podurgiel, et al. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. Neuroscience. 2013 Oct 10;250:507-19. doi: 10.1016/j.neuroscience.2013.07.008. Epub 2013 Jul 15.

Shipping Conditions

Room temperature

Scientific Category

Reference Standards

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mmu-miR-7039-5p inhibitor
HY-RI03820-01 5 nmol

Mmu-miR-7039-5p inhibitor

Ask
View Details
Mmu-miR-7039-5p inhibitor
HY-RI03820-02 20 nmol

Mmu-miR-7039-5p inhibitor

Ask
View Details
Recombinant Bacillus subtilis Probable anti-sigma-M factor yhdK (yhdK), partial
MBS7069738 Inquire

Recombinant Bacillus subtilis Probable anti-sigma-M factor yhdK (yhdK), partial

Ask
View Details
IGFL2 Human shRNA Plasmid Kit (Locus ID 147920)
TR317936 1 Kit

IGFL2 Human shRNA Plasmid Kit (Locus ID 147920)

Ask
View Details
Mouse Monoclonal TM4SF4 Antibody (832441) [DyLight 755]
FAB7998Z 0.1 mL

Mouse Monoclonal TM4SF4 Antibody (832441) [DyLight 755]

Ask
View Details
Anti-Human ALB/Albumin/HSA Monoclonal Antibody (1A390)
MHC01402 100 μg

Anti-Human ALB/Albumin/HSA Monoclonal Antibody (1A390)

Ask
View Details